You are currently viewing a new version of our website. To view the old version click .

Diagnostics, Volume 3, Issue 4

December 2013 - 4 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

  • Feature Paper
  • Article
  • Open Access
17 Citations
9,998 Views
13 Pages

29 October 2013

Neoplastic tissue exhibits high glucose utilization and over-expression of glucose transporters (GLUTs) and hexokinases (HKs), which can be imaged by 18F-Fluorodeoxyglucose-positron emission tomography (FDG-PET). The aim of the present study was to...

  • Review
  • Open Access
226 Citations
36,722 Views
28 Pages

29 October 2013

There have been continuous advances in the field of glucose monitoring during the last four decades, which have led to the development of highly evolved blood glucose meters, non-invasive glucose monitoring (NGM) devices and continuous glucose monito...

  • Review
  • Open Access
16 Citations
8,839 Views
16 Pages

21 October 2013

Surgeries’ sterile conditions and perioperative antibiotic therapies decrease implant associated infections rates significantly. However, up to 10% of orthopedic devices still fail due to infections. An implant infection generates a high socio-econom...

  • Article
  • Open Access
34 Citations
9,364 Views
12 Pages

Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor

  • Yin Wu,
  • Andreas Klaus Pfeifer,
  • Rebecca Myschetzky,
  • Rajendra Singh Garbyal,
  • Palle Rasmussen,
  • Ulrich Knigge,
  • Michael Bzorek,
  • Michael Holmsgaard Kristensen and
  • Andreas Kjaer

2 October 2013

Peptide receptor radionuclide therapy (PRRT) is a relatively new mode of internally targeted radiotherapy currently in clinical trials. In PRRT, ionizing radioisotopes conjugated to somatostatin analogues are targeted to neuroendocrine tumors (NETs)...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Diagnostics - ISSN 2075-4418